News Detail
Mumbai, 9 Jan 2024: India is poised to be an emerging hub for biologics and biosimilars with an estimated CAGR of 22% in the near future. It, today, has 200 plus biosimilars in pipeline and 98 biosimilars approved in FY19 in the US and EU. It is also strongly foraying into innova......
View Details
Source : Pharmabiz
biologics & biosimilars
DOP
Vibrant Gujarat
Related News
- AI can make drug-testing more precise, relevant to human biology (14-02-2025)
- Ayurvedic 'STONE NILL DS Syrup' claiming to treat 'Kidney Stones - Renal Calculi and Urethral Calculi' seized (14-02-2025)
- ED raids Niti Sen Bhatia's residence in Panipat (14-02-2025)
- Draft Guidelines for Processing Patent Applications of AYUSH Systems and Related Inventions (13-02-2025)
- FDA cracks down on online sale of MTP kits in Ghaziabad and Badaun, 227 seized (13-02-2025)
- Nepalese youth arrested with large quantity of drugs (13-02-2025)
- Seizure of Prohibited Drug Tablets in Pali (13-02-2025)
- Cosmetics with high methanol content seized in Kochi; used as aftershave (13-02-2025)
- ‘Sodium Phosphates Enema BP,’ claimed to treat ‘Convulsions’ seized (12-02-2025)
- Substandard Medicines issue raised in Rajya Sabha (12-02-2025)